Guo M - Search Results

1

EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.

Guo M, Price MJ, Patterson DG, Barwick BG, Haines RR, Kania AK, Bradley JE, Randall TD, Boss JM, Scharer CD. Guo M, et al. J Immunol. 2018 Feb 1;200(3):1039-1052. doi: 10.4049/jimmunol.1701470. Epub 2017 Dec 29. J Immunol. 2018. PMID: 29288200 Free PMC article.

2

Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs.

Scharer CD, Barwick BG, Guo M, Bally APR, Boss JM. Scharer CD, et al. Among authors: guo m. Nat Commun. 2018 Apr 27;9(1):1698. doi: 10.1038/s41467-018-04125-8. Nat Commun. 2018. PMID: 29703886 Free PMC article.

3

Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.

Kania AK, Guo M, Scharer CD, Boss JM. Kania AK, et al. Among authors: guo m. Immunohorizons. 2021 Dec 8;5(12):918-930. doi: 10.4049/immunohorizons.2000087. Immunohorizons. 2021. PMID: 34880105 Free PMC article.

4

EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance.

Yang Y, Li M, Zhu Y, Liu K, Liu M, Liu Y, Zhu G, Luo H, Zuo X, Zhang H, Guo M. Yang Y, et al. Among authors: guo m. Int Immunopharmacol. 2023 Jun;119:110155. doi: 10.1016/j.intimp.2023.110155. Epub 2023 Apr 10. Int Immunopharmacol. 2023. PMID: 37044035

5

EZH2: Its regulation and roles in immune disturbance of SLE.

Yang Y, Liu K, Liu M, Zhang H, Guo M. Yang Y, et al. Among authors: guo m. Front Pharmacol. 2022 Oct 13;13:1002741. doi: 10.3389/fphar.2022.1002741. eCollection 2022. Front Pharmacol. 2022. PMID: 36313363 Free PMC article. Review.

6

EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification.

Yang Y, Li M, Ding L, Zhang Y, Liu K, Liu M, Li Y, Luo H, Zuo X, Zhang H, Guo M. Yang Y, et al. Among authors: guo m. J Autoimmun. 2024 Dec;149:103341. doi: 10.1016/j.jaut.2024.103341. Epub 2024 Nov 21. J Autoimmun. 2024. PMID: 39577129

7

MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis.

Li Y, Huang J, Guo M, Zuo X. Li Y, et al. Among authors: guo m. Genomics Proteomics Bioinformatics. 2015 Aug;13(4):234-41. doi: 10.1016/j.gpb.2015.07.001. Epub 2015 Sep 11. Genomics Proteomics Bioinformatics. 2015. PMID: 26365208 Free PMC article. Review.

8

Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis.

Guo M, Liu D, Jiang Y, Chen W, Zhao L, Bao D, Li Y, Distler JHW, Zhu H. Guo M, et al. Metabolism. 2023 Jul;144:155587. doi: 10.1016/j.metabol.2023.155587. Epub 2023 May 6. Metabolism. 2023. PMID: 37156409

9

Negative regulator IL-1 receptor 2 (IL-1R2) and its roles in immune regulation of autoimmune diseases.

Zhang Y, Liu K, Guo M, Yang Y, Zhang H. Zhang Y, et al. Among authors: guo m. Int Immunopharmacol. 2024 Jul 30;136:112400. doi: 10.1016/j.intimp.2024.112400. Epub 2024 Jun 7. Int Immunopharmacol. 2024. PMID: 38850793 Review.

10

Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis.

Xie S, Bao D, Xiao Y, Li H, Guo M, Dai B, Liu S, Huang J, Li M, Ding L, Meng Q, Lv CL, Distler JHW, Luo H, Zhu H. Xie S, et al. Among authors: guo m. J Autoimmun. 2024 Dec;149:103306. doi: 10.1016/j.jaut.2024.103306. Epub 2024 Sep 12. J Autoimmun. 2024. PMID: 39265192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,626 results

Search Page

Filters